Menu

• Home
• News
• • 2024-2027
  • 2020-2023
  • 2016-2019
  • 2013-2015
    • The complexity of cell composition of the intima of large arteries: Focus on pericyte-like cells.
    • [Direct antiatherosclerotic therapy: possible approaches, results of clinical trials].
    • Role of Bone-Type Tissue-Nonspecific Alkaline Phosphatase and PHOSPO1 in Vascular Calcification.
    • Blood Serum Atherogenicity and Coronary Artery Calcification.
    • Mechanisms of Medial Arterial Calcification in Diabetes.
    • Effect of sex hormones on levels of mRNAs coding for proteins involved in lipid metabolism in macrophages.
    • Coordination in gene expression during atherogenesis.
    • Changes in levels of gene expression in human aortal intima during atherogenesis.
    • Interaction of native and modified low density lipoprotein with intimal cells in atherosclerotic lesion
    • Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy.
    • Direct anti-atherosclerotic therapy; development of natural anti-atherosclerotic drugs preventing cellular cholesterol retention.
    • Vascular extracellular matrix in atherosclerosis.
    • Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response.
    • Anti-atherosclerotic therapy based on botanicals.
    • Diagnostic and prognostic value of low density lipoprotein-containing circulating immune complexes in atherosclerosis.
    • Low density lipoprotein-containing circulating immune complexes have better prognostic value in carotid intima-media thickness progression than other lipid parameters.
    • Increased shedding of microvesicles from intimal smooth muscle cells in athero-prone areas of the human aorta: implications for understanding of the predisease stage.
  • 2009-2012
    • Macrophages and lipoprotein metabolism in atherosclerotic lesion
    • Widespread distribution of HLA-DR-expressing cells in macroscopically undiseased intima of the human aorta: a possible role in surveillance and maintenance of vascular homeostasis.
    • Anti-Atherosclerotic Therapy Based on Botanicals.
    • Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
    • Diagnostic and Prognostic Value of Low Density Lipoprotein-Containing Circulating Immune Complexes in Atherosclerosis.
    • Low density lipoprotein-containing circulating immune complexes have better prognostic value in carotid intima-media thickness progression than other lipid parameters.
    • Increased shedding of microvesicles from intimal smooth muscle cells in athero-prone areas of the human aorta: implications for understanding of the predisease stage.
    • Pluronic block copolymers inhibit low density lipoprotein self-association.
    • Cultured cell systems for revelation of new drugs antiatherosclerotic effects and their mechanisms investigation
    • Monocytes as a diagnostic marker of cardiovascular diseases.
    • Вариабельность показателя толщины комплекса интима медиа общих сонных артерий в московской городской популяции среди лиц без клинических проявлений атеросклероза.
    • Новый биомаркер в ранней диагностике цереброваскулярной патологии: диффузное интимо-медиальное утолщение сонных артерий.
    • Роль сиаловой кислоты в проявлении атерогенных свойств липопротеидами низкой плотности.
    • Иммунный холестерин в крови - прогностическая ценность.
    • Клеточные модели для поиска веществ, способствующих обратному транспорту холестерина.
    • Contents of mRNAs encoding endosome/lysosome components in normal human aorta and in stage II of atherogenesis: a hidden regulation.
    • Тест-система для изучения влияния фармакологических агентов на активацию моноцитов крови человека.
    • Анализ мутации митохондриального генома A1555G при атеросклерозе интимы аорты человека.
    • Детекция замены тимина на цитозин в позиции 3336 митохондриального генома при атеросклеротических поражениях человека.
    • Белок переноса фосфолипидов увеличивает отток клеточного холестерина и фосфолипидов, вызванный аполипопротеинами высокой плотности.
    • Сезонные изменения транссиалидазной активности сыворотки крови человека.
    • Correlation between lipid deposition, immune-inflammatory cell content and MHC class II expression in diffuse intimal thickening of the human aorta.
    • Опыт применения пребиотика пролонгированного действия алликор.
    • Полиморфизм 3256С/Т митохондриальной ДНК как маркер ишемической болезни сердца и атеросклероза.
    • Детекция митохондриальной делеции гуанина в позиции 652 при атеросклеротических поражениях человека.
    • Клеточные модели для поиска средств, способствующих обратному транспорту холестерина.
    • Изучение показателя толщины интимо-медиального слоя сонных артерий (ТИМ) как показателя естественного течения атеросклероза в московской популяции.
    • Массовая апробация эффективности пребиотического препарата «Алликор» в отношении показателей заболеваемости острыми респираторными вирусными инфекциями у детей.
    • Результаты апробации пребиотика «Алликор» в условиях оздоровительной программы по профилактике респираторных и сердечно-сосудистых заболеваний.
    • Исследование влияния белков, потенциально вовлеченных в отток холестерина, на экспорт холестерина из макрофагов.
    • Липопротеиды низкой плотности подавляют воспалительную реакцию моноцитов.
    • Индуцирующая роль вирусов острых респираторных вирусных инфекций в прогрессии атеросклеротического процесса.
    • Ультразвуковые признаки каротидного атеросклероза в диагностике ранних нарушений мозгового кровообращения.
    • Повреждение механизмов обратного транспорта холестерина, вызванное вирусом иммунодефицита человека: роль АВСА1-зависимого пути.
    • Возможная роль экологических факторов в формировании предрасположенности к развитию атеросклероза в московской популяции.
    • Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension.
    • Роль диффузного интимо-медиального утолщения сонных артерий в ранней диагностике цереброваскулярной патологии.
    • Peculiarities of cell composition and cell proliferation in different type atherosclerotic lesions in carotid and coronary arteries.
    • Прямая количественная оценка мутантного аллеля митохондриального генома.
    • Изучение программирующего эффекта половых гормонов на клеточной модели накопления холестерина.
    • Долговременная динамика изменений способности сыворотки крови человека вызывать накопление холестерина в клеточной тест-системе.
    • Выделение моноцитов из крови человека для изучения влияния факторов внешней среды на иммунитет.
    • Толщина интимо-медиального слоя сонных артерий как фенотипический маркер ишемической болезни сердца.
    • Оценка противовоспалительной активности препарата «Инфламинат» на животной модели воспаления.
    • Механизмы половых различий при атеросклерозе.
    • Сиаломика и атеросклероз.
    • Липопротеиды высокой плотности: терапевтические подходы (ЛВП-терапия).
    • Клеточные механизмы атеросклероза: врожденный иммунитет и воспаление.
    • Влияние паратиреоидного гормона на протеом остеобластов.
    • Мутации митохондриального генома в патологии человека.
    • Ассоциация мутации митохондриального генома 652insG с атеросклеротическими поражениями человека.
    • Musashi-1 expression in atherosclerotic arteries and its relevance to the origin of arterial smooth muscle cells: Histopathological findings and speculations.
  • 2006-2008
    • Сравнительное содержание мРНК рецепторов и ферментов обмена половых стероидов в ткани артериальных сосудов мужчин.
    • Complex reduction of cardiovascular prognostic risk with time-released garlic powder tablets allicor.
    • Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study.
    • Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
    • Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy.
    • Deglycosylation of apo B-containing lipoproteins increase their ability to aggregate and to promote intracellular cholesterol accumulation in vitro.
    • Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study.
    • Связь размера дегликозилированных различными ферментами апо-В-содержащих липопротеидов с их атерогенным потенциалом.
    • Антиатерогенный эффект флавоноидов винограда в модели ex vivo.
    • Time-released garlic powder tablets protect from acute respiratory diseases and reduce overall mortality.
    • Заряд поверхностного слоя циркулирующих множественно модифицированных липопротеинов низкой плотности.
    • Влияние экстрактов растительного происхождения на активность транс-сиалидазы плазмы крови человека.
    • Подавление внутриклеточного накопления холестерина и экспрессии провоспалительных цитокинов в условиях клеточной модели.
    • Агрегация ЛПНП, индуцированная окислением, приводит к увеличению их захвата гладкомышечными клетками аорты человека.
    • Применение натуральных продуктов в антицитокиновой терапии.
    • Применение алликора для снижения риска инфаркта миокарда.
  • 2002-2005
    • Оценка эффективности алликора для снижения риска развития ишемической болезни сердца при первичной профилактике.
    • Протеолиз апопротеида В-100 нарушает его топографию на поверхности ЛПНП, снижая их устойчивость к ассоциации.
    • Гидролиз фосфолипидов фосфолипазами А2 и С нарушает конформацию аполипопротеина В-100 на поверхности липопротеидов низкой плотности, снижая их устойчивость к ассоциации.
    • Десиалирование снижает устойчивость апо-В-содержащих липопротеидов к ассоциации, повышая их атерогенный потенциал.
    • Снижение риска сердечно-сосудистых заболеваний при первичной профилактике ишемической болезни сердца.
    • Garlic powder tablets in direct prevention and treatment of atherosclerosis.
    • Сравнение устойчивости к ассоциации нативных и циркулирующих модифицированных ЛПНП крови человека.
    • Циркулирующие модифицированные ЛПНП крови человека склонны к ассоциации в условиях пониженной ионной силы.
    • Миелопероксидаза, модифицируя поверхность и снижая устойчивость к ассоциации липопротеинов низкой плотности крови человека, повышает их атерогенный потенциал.
    • Способ лечения мастопатии.
    • Гипотензивный эффект чесночных таблеток пролонгированного действия Алликор (двойное слепое плацебо-контролируемое исследование).
    • New insight into non-statin prevention and treatment of atherosclerosis.
    • Human plasma trans-sialidase donor and acceptor specificity.
    • Влияние чесночных таблеток пролонгированного действия Алликор на заболеваемость ОРВИ у детей.
    • Атерогенные холестеринсодержащие циркулирующие иммунные комплексы в сыворотке крови больных системной красной волчанкой.
    • Способ лечения хронического атрофического гастрита.
    • Коррекция гиперлипидемии препаратом Алликор.
    • Изучение антиоксидантного препарата «Каринат» как средства для лечения больных с хроническим атрофическим гастритом.
    • Выявление антигенных различий апо-В нативных и циркулирующих модифицированных ЛПНП.
    • Изучение антиоксидантной биологически активной добавки к пище "Каринат" у больных с фиброаденоматозом молочных желез.
  • 1997-2001
    • Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.
    • Continuous subendothelial network formed by pericyte-like cells in human vascular bed.
    • Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
    • In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.
    • Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions.
    • Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.
    • Optimization of the assay for sialic acid determination in low density lipoprotein.
    • Многофакторная профилактика атеросклероза и атеросклеротических заболеваний.
    • Применение алликора для коррекции метаболизма при сахарном диабете: биохимические предпосылки и клинические исследования.
    • Прямое антиатеросклеротическое действие Алликора. Двойное слепое плацебо-контролируемое многоцентровое исследование.
    • The content of lipoperoxidation products in normal and atherosclerotic human aorta.
    • [Localization of collagen-synthesizing cells in normal and atherosclerotic intima of human aorta] [in Russian]
    • Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential.
    • Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
    • Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta
    • [Effect of the garlic tablets allicor on thrombocyte aggregation in vitro and ex vivo] [in Russian]
    • Effects of garlic on atherosclerosis.
    • In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells.
    • Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin.
    • The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells.
    • [New prospects for the treatment of atherosclerosis: garlic preparations] [in Russian]
  • 1993-1996
    • Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein.
    • [Multiple modifications of low density lipoproteins in blood of patients with atherosclerosis] [in Russian]
    • Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    • Gap junctional communication in primary culture of cells derived from human aortic intima.
    • Diagnostic value of immune cholesterol as a marker for atherosclerosis.
    • [Intercellular communication studied by using the gap junctions in a primary cell culture of human aortic intima] [in Russian]
    • [Multiply-modified disialyated low-density lipoproteins: physico-chemical properties] [in Russian]
    • Characteristics of low density lipoprotein isolated from circulating immune complexes.
    • [Direct antiatherogenic effect of garlic] [in Russian]
    • Atherogenic modified LDL in diabetes.
    • [Lipid composition of polymodified (desialylated) low density lipoproteins] [in Russian]
    • [Immunocytochemical study to localize a scavenger receptor in human aorta smooth muscle cells] [in Russian]
    • [Protein-bound lipids in human low density lipoproteins] [in Russian]
    • Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
    • [Decrease in atherogenicity of blood serum in vitro under the effect of polyunsaturated phosphatidylcholine micelles] [in Russian]
    • Direct anti-atherosclerosis-related effects of garlic.
    • Heterogeneity of smooth muscle cells in embryonic human aorta.
    • [Atherogenic properties of oral sugar-reducing sulfonylurea derivatives] [in Russian]
    • Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.
    • Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages.
    • [The antiatherosclerotic effect of verapamil in a cell culture of human aortic intima] [in Russian]
    • [Atherogenic properties of blood serum in children with type I diabetes mellitus] [in Russian]
    • Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.
    • Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease.
    • [Effect of squid liver fat and krill meat on blood serum atherogenicity in patients with type I diabetes mellitus] [in Russian]
    • [Atherogenic potential of blood serum in patients with type I diabetes mellitus] [in Russian]
    • Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
    • [Atherogenic effect of sugar-reducing drugs of the sulfonylurea group and its elimination using papaverine chloride] [in Russian]
    • Effect of lipoprotein (a) on lipid metabolism of cultured human intimal aortic cells.
  • 1991-1992
    • Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
    • [The structure of the endothelialized and nonendothelialized areas of myointimal thickening of the rabbit aorta] [in Russian]
    • The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta.
    • [Effects of lovastatin therapy on the level of low density lipoproteins and atherogenic potential of serum in patients with ischemic heart disease and hypercholesterolemia] [in Russian]
    • [Atherogenic properties of phenothiazine drugs manifesting in cultured cells of the human aortic intima] [in Russian]
    • Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine.
    • Lipid-laden white blood cells in the circulation of patients with coronary heart disease.
    • [Carbohydrate composition of native and desialylated low density lipoproteins in the plasma of patients with coronary atherosclerosis] [in Russian]
    • [The effect of calcium antagonists on cholesterol metabolism in human aortal intima cells and macrophage lines] [in Russian]
    • [Seasonal variations of the lipid spectrum in patients with post-infarction cardiosclerosis and arterial hypertension] [in Russian]
    • Use of cultured atherosclerotic cells for investigation of antiatherosclerotic effects of anipamil and other calcium antagonists.
    • Influence of a cholesterol rich diet in rabbits on the formation of PGI2 and TXA2.
    • [Comparison between seasonal changes in lipid indicators in patients with post-infarction cardiosclerosis and arterial hypertension in Ashkhabad and Moscow] [in Russian]
    • Stellate cells of aortic intima: I. Human and rabbit.
    • Stellate cells of aortic intima: II. Arborization of intimal cells in culture.
    • Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil.
    • Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.
    • [Elimination of the atherogenic effect of beta blocker propranolol by papaverine] [in Russian]
    • Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation in human aortic intimal cells--the role of lipoprotein aggregation.
    • [Relations between the levels of lipoprotein-containing immune complexes and lipids in the blood of patients with ischemic heart disease] [in Russian]
    • [Circulating immune complex cholesterol as a biochemical marker of coronary atherosclerosis] [in Russian]
    • [The cellular polymorphism of the myointimal thickening in the rabbit aorta] [in Russian]
    • Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.
    • [Atherogenic effect of beta-blocker propranolol revealed in the rabbit denudated aorta] [in Russian]
    • Synergetic effect of desialylated and glycated low density lipoproteins on cholesterol accumulation in cultured smooth muscle intimal cells.
    • [Combined effects of desialylated and glycosylated low density lipoproteins on lipid content of human aortic intima cells in vitro] [in Russian]
    • [Atherogenic properties of sera and low-density lipoproteins in patients with diabetes mellitus] [in Russian]
    • Atherogenicity of autoantibodies against low density lipoprotein.
    • [Structure of the neointima after balloon catheter injury of the rabbit aorta in the context of hypercholesterolemia: analysis of endothelial influence on lipid accumulation] [in Russian]
    • Cholesterol level in circulating immune complexes as a marker of coronary atherosclerosis.
    • Antibody-like immunoglobulins G against low density lipoprotein that stimulate lipid accumulation in cultured cells.
    • [Changes in the 3-dimensional organization of the cellular system of the human aortic intima in atherosclerosis] [in Russian]
    • [The cholesterol content in immune complexes as a marker of coronary and peripheral atherosclerosis] [in Russian]
    • Lipoprotein immune complexes as markers of atherosclerosis.
    • Quantitative estimation of lipid-laden cells in atherosclerotic lesions of the human aorta.
    • Use of human atherosclerotic cells for optimization of antiatherosclerotic therapy.
    • Lipids in cells of atherosclerotic and uninvolved human aorta. III. Lipid distribution in intimal sublayers.
  • 1989-1990
    • [Blood lipophages in patients with ischemic heart disease] [in Russian]
    • In vitro models of anti-atherosclerotic effects of cardiovascular drugs.
    • [Isolation of desialylated low density lipoproteins from the blood of patients with ischemic heart disease by affinity chromatography] [in Russian]
    • Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red cells.
    • Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography.
    • Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture.
    • Antiatherosclerotic effects of calcium antagonists. Study in human aortic cell culture.
    • [Effects of beta adrenergic blocking agents and calcium antagonists on atherogenic properties of blood serum of patients with ischemic heart disease] [in Russian]
    • Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis.
    • [Aggregates of modified low density lipoproteins indicate accumulation of lipids in human aortic intima cells in vitro] [in Russian]
    • [Incidence among men of atherogenic potential of the serum detected in a culture of mouse peritoneal macrophages] [in Russian]
    • [Desialylated low density lipoproteins--atherogenic lipoproteins occurring in blood of patients with coronary atherosclerosis] [in Russian]
    • [Lysosomal proteinases of the human aortal intima and atherogenesis] [in Russian]
    • Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients.
    • Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins.
    • [Cholesterol-containing circulating immune complexes--a component of the blood serum in patients with ischemic heart disease that determines its atherogenic properties] [in Russian]
    • Insolubilization of low density lipoprotein induces cholesterol accumulation in cultured subendothelial cells of human aorta.
    • [The effect of glucagon and concanavalin A on cholesterol accumulation in mouse peritoneal macrophages and human aorta intima cells] [in Russian]
    • Peritoneal macrophages: a model for detecting atherogenic potential in patients' blood serum.
    • [The use of freeze fracturing in combination with light, scanning and transmission electron microscopy for studying the structure of the normal and atherosclerotically altered human aortic intima] [in Russian]
    • [Peritoneal macrophages as a model for the study of the atherogenic potential of the blood serum] [in Russian]
    • [Low density lipoproteins isolated from the blood of patients with ischemic heart disease induce accumulation of lipids in human aortic intima cells] [in Russian]
    • [Anti-atherosclerotic properties of higher mushrooms (a clinico-experimental investigation)] [in Russian]
    • Use of lipophilic fluorescent probes for the isolation of hybrid cells in flow cytometry.
    • [The effect of eicosapentaenoic acid and various prostaglandins on cholesterol accumulation and proliferation of intima cells from human aorta] [in Russian]
    • [Effect of medicinal leech preparations on indicators of atherogenesis] [in Russian]
    • [The content of cyclic nucleotides in an organ culture of normal and atherosclerosis-affected human aorta] [in Russian]
    • [Anti-atherosclerotic properties of eicosapentaenoic acid: clinico-experimental study] [in Russian]
    • Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells.
    • [Atherogenic properties of beta adrenergic blockaders evident on vascular wall cells] [in Russian]
    • Ganglioside content and composition of cells from normal and atherosclerotic human aorta.
  • 1986-1988
    • Atherogenic effects of beta blockers on cells cultured from normal and atherosclerotic aorta.
    • Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists.
    • Prevention of experimental carotid artery thrombosis by magnetic vectoring of aspirin [letter]
    • [Effect of components of the extracellular matrix on the accumulation of lipids in human cells] [in Russian]
    • [Decreased lipid levels in arteriosclerotic plaques of the human aorta after LDL-apheresis (an in vitro study)] [in Russian]
    • Spontaneous atherosclerotic plaque and obstruction of distal anastomosis in femoral artery. Comparative morphologic study.
    • Cyclic nucleotides and atherosclerosis: studies in primary culture of human aortic cells.
    • [Effect of lipostabil on cholesterol levels in atherosclerotic plaques of the human aorta and the aggregative capacity of thrombocytes (in vitro study)] [in Russian]
    • Intracellular cholesterol accumulation is accompanied by enhanced proliferative activity of human aortic intimal cells.
    • Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells.
    • The effects of eicozanoids and lipoxygenase inhibitors on the lipid metabolism of aortic cells.
    • Prostacyclin, thromboxane A2 and calcium antagonists: effects on atherosclerotic characteristics of vascular cells.
    • [Comparison of 2 methods of flow cytofluorometric analysis of epithelial cells in the diagnosis of uterine cervix cancer] [in Russian]
    • On the role of cyclic nucleotides in the pathogenesis of human atherosclerosis.
    • Is prostacyclin a major prostaglandin produced by endothelial cells in culture?
    • Disorders in the system of cyclic nucleotides in atherosclerosis: cyclic AMP and cyclic GMP content and activity of related enzymes in human aorta.
    • Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells.
    • Association of low-density lipoprotein with particulate connective tissue matrix components enhances cholesterol accumulation in cultured subendothelial cells of human aorta.
    • Trapidil derivatives as potential antiatherosclerotic drugs.
    • [Local prevention of thrombosis in the dog carotid artery using magnetically concentrated erythrocytes loaded with aspirin] [in Russian]
    • Diabetes mellitus and atherosclerosis [letter]
    • Adult human aortic cells in primary culture: heterogeneity in shape.
    • Agents that increase cellular cyclic AMP inhibit proliferative activity and decrease lipid content in cells cultured from atherosclerotic human aorta.
    • Cyclic AMP and cyclic GMP content in a short-term organ culture of normal and atherosclerotic human aorta.
    • Monoclonal antibody reveals heterogeneity in human aortic intima: detection of a ganglioside antigen associated with a subpopulation of intimal cells [published erratum appears in Am J Pathol 1986 May;123(2):379]
    • Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents.
    • Atherogenicity of blood serum from patients with coronary heart disease.
    • Effect of cyclic AMP on lipid accumulation and metabolism in human atherosclerotic aortic cells.
    • Low-density lipoprotein apheresis and regression of atherosclerotic plaque in vitro.
    • Comparative investigations of the reoccluded distal anastomosis, the spontaneous atherosclerotic plaque and the normal intima of the human femoral artery.
  • 1974-1985
    • [Study of the structural and functional properties of fibronectin--a high molecular weight plasma glycoproteins--by using monoclonal antibodies] [in Russian]
    • Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta.
    • Artificial HDL as an anti-atherosclerotic drug [letter]
    • [Cellular composition and biochemical characteristics of the human aorta] [in Russian]
    • Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme-isolated and cultured cells.
    • Primary RIA screening of hybridoma supernatants without use of a negative control.
    • Determination of total intracellular lipid content by flow cytofluorometry.
    • LDL apheresis and regression of atherosclerosis [letter]
    • Lipids in cells of atherosclerotic and uninvolved human aorta. II. Lipid metabolism in primary culture.
    • [Concentration of erythrocyte-based magnetic carriers in the vascular bed] [in Russian]
    • [Immunomorphological study of the localization of types I, III, IV and V collagen in a primary culture of human aortic cells] [in Russian]
    • Dissociated cells from different layers of adult human aortic wall.
    • Primary cultures of enzyme-isolated cells from normal and atherosclerotic human aorta.
    • Regression of atherosclerotic manifestations in primary culture of human aortic cells: effects of prostaglandins.
    • Enzymatic detoxication of superoxide anion-radicals and lipoperoxides in intima and media of atherosclerotic aorta.
    • [Determination of the lipid content of a single cell by flow cytofluorometry] [in Russian]
    • Heterogeneity of human aortic cells in regard to RNA content.
    • [Decrease in the lipid content of human atherosclerotic aorta cells as affected by compounds increasing the intracellular level of cyclic AMP] [in Russian]
    • [Immunomorphological study of fibronectin localization in a primary human aorta cell culture] [in Russian]
    • [Detection of 2 cell subpopulations each differing in incorporating low-density lipoproteins in an atherosclerotic plaque from the human aorta] [in Russian]
    • Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta.
    • Stellate cells in the intima of human aorta. Application of alkaline dissociation method in the analysis of the vessel wall cellular content.
    • [Use of perilenoyl-labelled triglyceride as a fluorescent probe for staining lipid inclusions in cultured cells] [in Russian]
    • Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content.
    • [Effect of dibutyryl-cAMP on the cholesterol ester content in human atherosclerotic aorta cells] [in Russian]
    • Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture.
    • [3H-thymidine incorporation into human aorta cells in primary culture. An autoradiographic study] [in Russian]
    • Prostacyclin analogues as antiatherosclerotic drugs [letter]
    • [Content of lipids in cells, isolated from normal and atherosclerotically-altered portions of the human aorta] [in Russian]
    • [Role of endogenic substances in creating a background of increased radioresistance. 3. The role of endogenic serotonin] [in Russian]
    • [Role of endogenous substances in developing a basis for increased radiation resistance. 4. Effect of serotonin on lipid radiation sensitizers] [in Russian]
    • [A method of determining adenylate cyclase activity] [in Russian]
    • [Role of endogenous substances in the creation of a background of increased radioresistance. Report 7. Study of the influence of dopamine and histamine on lipid radiosensitizers] [in Russian]
    • [Effect of radiation-protective preparations on the level of cyclic adenosine-3',5'-monophosphate (cycl AMP), adenylate cyclase and cycl AMP phosphodiesterase] [in Russian]
    • [Effect of ionizing radiation on the activity of adenylate cyclase, cAMP phosphodiesterase and the level of cAMP in mouse liver] [in Russian]
    • [Post-radiation disorders in the cyclic AMP system of mouse spleen and thymus lymphoid cells] [in Russian]
    • [Polymorphism of human aortic cells in culture] [in Russian]
    • [RNA content of cells isolated from normal and arteriosclerotic human aorta] [in Russian]
    • [Lipid metabolism in cells of human atherosclerotic aorta. Study in the primary culture] [in Russian]
  • Publications from 2016 to 2019
  • Publications from 2013 to 2015
  • Publications from 2009 to 2012
  • Publications from 2006 to 2008
  • Publications from 2002 to 2005
  • Publications from 1997 to 2001
  • Publications from 1993 to 1996
  • Publications from 1991 to 1992
  • Publications from 1989 to 1990
• • Direct anti-atherosclerotic therapy
• • Lectures International Youth Scientific School
• • Консультация по профилактике, диагностике и лечению атеросклероза.
  • Conrtacted studies
  • Требуется сотрудник для работы с базами данных
  • Научная школа для молодежи "Российско-скандинавская школа "Генодиагностика атеросклероза. Митохондриальный геном""
• Partners
• Патенты
• О нас пишут
• Контракты
• Наши награды и сертификаты
• Сотрудники
• Методические рекомендации

Top Menu

• About us
• Institute structure
• Resume
• Вакансии
• Contact us
• Поиск